Health In Tech (NASDAQ:HIT) vs. Marsh & McLennan Companies (NYSE:MRSH) Head-To-Head Survey

Marsh & McLennan Companies (NYSE:MRSH) and Health In Tech (NASDAQ:HIT) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations.

Risk and Volatility

Marsh & McLennan Companies has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Health In Tech has a beta of 7.93, meaning that its share price is 693% more volatile than the S&P 500.

Institutional & Insider Ownership

88.0% of Marsh & McLennan Companies shares are held by institutional investors. 0.4% of Marsh & McLennan Companies shares are held by company insiders. Comparatively, 77.7% of Health In Tech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Marsh & McLennan Companies and Health In Tech’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Marsh & McLennan Companies	15.42%	31.60%	8.26%
Health In Tech	N/A	N/A	N/A

Earnings & Valuation

This table compares Marsh & McLennan Companies and Health In Tech”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marsh & McLennan Companies	$26.98 billion	3.31	$4.16 billion	$8.43	21.90
Health In Tech	$30.72 million	3.00	$1.71 million	$0.03	54.00

Marsh & McLennan Companies has higher revenue and earnings than Health In Tech. Marsh & McLennan Companies is trading at a lower price-to-earnings ratio than Health In Tech, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings for Marsh & McLennan Companies and Health In Tech, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marsh & McLennan Companies	1	11	6	1	2.37
Health In Tech	1	0	0	1	2.50

Marsh & McLennan Companies currently has a consensus target price of $216.18, indicating a potential upside of 17.09%. Health In Tech has a consensus target price of $2.50, indicating a potential upside of 54.32%. Given Health In Tech’s stronger consensus rating and higher possible upside, analysts plainly believe Health In Tech is more favorable than Marsh & McLennan Companies.

Summary

Marsh & McLennan Companies beats Health In Tech on 9 of the 14 factors compared between the two stocks.

About Marsh & McLennan Companies

Marsh & McLennan Cos., Inc. is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services. The Consulting segment offers health, wealth, and career solutions and products, and specialized management, strategic, economic, and brand consulting services. The company was founded by Henry W. Marsh and Donald R. McLennan in 1871 and is headquartered in New York, NY.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.